Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH LUPIN PANACEA BIOTECH/
LUPIN
 
P/E (TTM) x -60.9 40.7 - View Chart
P/BV x 0.9 6.0 14.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PANACEA BIOTECH   LUPIN
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
LUPIN
Mar-23
PANACEA BIOTECH/
LUPIN
5-Yr Chart
Click to enlarge
High Rs191799 24.0%   
Low Rs107583 18.4%   
Sales per share (Unadj.) Rs75.1365.8 20.5%  
Earnings per share (Unadj.) Rs-5.59.8 -56.0%  
Cash flow per share (Unadj.) Rs0.929.2 3.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs137.7270.7 50.9%  
Shares outstanding (eoy) m61.25454.98 13.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.9 105.2%   
Avg P/E ratio x-27.170.2 -38.6%  
P/CF ratio (eoy) x170.023.7 718.2%  
Price / Book Value ratio x1.12.6 42.5%  
Dividend payout %040.7 -0.0%   
Avg Mkt Cap Rs m9,142314,381 2.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,26530,872 4.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,599166,417 2.8%  
Other income Rs m5171,509 34.2%   
Total revenues Rs m5,116167,926 3.0%   
Gross profit Rs m4717,206 0.3%  
Depreciation Rs m3918,807 4.4%   
Interest Rs m442,743 1.6%   
Profit before tax Rs m1287,165 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4662,688 17.3%   
Profit after tax Rs m-3374,477 -7.5%  
Gross profit margin %1.010.3 9.9%  
Effective tax rate %363.537.5 969.0%   
Net profit margin %-7.32.7 -272.7%  
BALANCE SHEET DATA
Current assets Rs m5,623124,513 4.5%   
Current liabilities Rs m3,29792,654 3.6%   
Net working cap to sales %50.619.1 264.1%  
Current ratio x1.71.3 126.9%  
Inventory Days Days5926 223.9%  
Debtors Days Days4898 48.5%  
Net fixed assets Rs m7,028103,490 6.8%   
Share capital Rs m61910 6.7%   
"Free" reserves Rs m8,375122,246 6.9%   
Net worth Rs m8,436123,156 6.8%   
Long term debt Rs m202275 73.3%   
Total assets Rs m12,712228,003 5.6%  
Interest coverage x3.93.6 107.6%   
Debt to equity ratio x00 1,070.0%  
Sales to assets ratio x0.40.7 49.6%   
Return on assets %-2.33.2 -72.8%  
Return on equity %-4.03.6 -110.0%  
Return on capital %2.08.0 24.9%  
Exports to sales %43.30-   
Imports to sales %24.40-   
Exports (fob) Rs m1,992NA-   
Imports (cif) Rs m1,124NA-   
Fx inflow Rs m1,99248,057 4.1%   
Fx outflow Rs m1,19121,752 5.5%   
Net fx Rs m80126,306 3.0%   
CASH FLOW
From Operations Rs m-4,22518,972 -22.3%  
From Investments Rs m4,303-12,868 -33.4%  
From Financial Activity Rs m-184-3,373 5.4%  
Net Cashflow Rs m-1052,732 -3.8%  

Share Holding

Indian Promoters % 73.6 46.8 157.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 1.0 45.8 2.1%  
FIIs % 0.3 16.1 1.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 53.0 49.9%  
Shareholders   47,091 281,542 16.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Lupin Share Price Performance

Period Panacea Biotech Lupin S&P BSE HEALTHCARE
1-Day -1.74% 1.23% 1.18%
1-Month -20.01% 0.15% -0.75%
1-Year 11.75% 151.14% 61.82%
3-Year CAGR -12.26% 17.13% 18.16%
5-Year CAGR -9.98% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.